With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector supports biotech and pharmaceutical R&D and commercialization by providing lab ...
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
Live Science on MSN
This is SPARDA: A self-destruct, self-defense system in bacteria that could be a new biotech tool
A bacterial defense system called SPARDA employs kamikaze-like tactics to protect cells and could be useful in future ...
Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...
MicroRNAs, whose discovery was recognized with the 2025 Nobel Prize in Physiology or Medicine, are central regulators of gene ...
The accurate early detection and precise localization of diseases remain pivotal challenges in modern medicine. Traditional diagnostic methods often grapple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback